Covalon Technologies Ltd. (OTCMKTS:CVALF) Shares Shorted: Short Interest Down 57.2% in October

Covalon Technologies Ltd. (OTCMKTS:CVALF – Get Free Report) saw a significant decline in short interest in October. As of October 15th, there was short interest totaling 24,176 shares, a decline of 57.2% from the September 30th total of 56,447 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 23,579 shares, the short-interest ratio is presently 1.0 days.

Covalon Technologies Stock Performance

Shares of Covalon Technologies stock opened at $3.17 on Friday. Covalon Technologies has a 52-week low of $1.16 and a 52-week high of $3.65. The firm has a market cap of $87.66 million, a PE ratio of 28.86 and a beta of 0.78. The business’s 50 day simple moving average is $2.64 and its 200 day simple moving average is $1.72.

Covalon Technologies (OTCMKTS:CVALF – Get Free Report) last announced its quarterly earnings results on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.06. The company had revenue of $7.07 million for the quarter, compared to analysts’ expectations of $6.65 million. Covalon Technologies had a net margin of 12.77% and a return on equity of 15.11%.

Covalon Technologies Company Profile

(Get Free Report)

Covalon Technologies Ltd. is a Canadian medical technology company that develops, manufactures and commercializes healthcare products designed to support wound care, infection prevention and surgical procedures. Its technologies are intended for use by hospitals, healthcare professionals and patients in managing wounds and protecting skin.

The company’s product portfolio includes advanced wound dressings, antimicrobial and protective barriers, surgical incision dressings, and other solutions for skin and tissue management.

Recommended Stories

Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.